BioWorld BioWorld MedTech BioWorld Asia

BioWorld

The eyes have it: Adcom slam-dunk vote favors Horizon thyroid candidate
As expected, Horizon Pharma plc sailed through the meeting of the FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee regarding the BLA for teprotumumab in thyroid...

More in BioWorld

BioWorld MedTech

FDA gives nod to first newborn screening test for Duchenne muscular dystrophy
Perkinelmer Inc., of Waltham, Mass., has won a thumbs up from the U.S. FDA for its GSP Neonatal Creatine Kinase-MM kit. The assay is the first test approved in the U.S. for...

More in BioWorld MedTech

BioWorld Asia

Australia’s R&D tax incentive threatened yet again
PERTH, Australia – Despite a Senate inquiry recommendation to hold off on introducing cuts to Australia’s Research and Development Tax Incentive (RDTI), a bill that...

More in BioWorld Asia